Estradiol and tamoxifen mediate rescue of the dominant-negative effects of estrogen response element-binding protein in vivo and in vitro

Endocrinology

Volumn 150, Issue 5, 2009, Pages 2429-2435

  Chen, Hong ^a   Clemens, Thomas L ^b   Hewison, Martin ^c   Adams, John S ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RESPONSIVE ELEMENT BINDING PROTEIN; PLACEBO; TAMOXIFEN; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; MATRIX ATTACHMENT REGION BINDING PROTEIN; NUCLEAR MATRIX PROTEIN; SAFB PROTEIN, HUMAN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST; CHROMATIN; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESISTANCE; ESTROGEN RESPONSIVE ELEMENT; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BLOOD; DOMINANT GENE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HISTOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; TUMOR CELL CULTURE; UDDER;

ANIMALS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, DOMINANT; HUMANS; MAMMARY GLANDS, ANIMAL; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; MICE, TRANSGENIC; NUCLEAR MATRIX-ASSOCIATED PROTEINS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 66449089620     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1148     Document Type: Article

References (36)

1. Aland ET 2006 Lives and times of nuclear receptors. Mol Endocrinol 20: 1972-1981
2. Hagenbaugh A, Sharma S, Dubinett SM, Wei SH, Aranda R, Cheroutre H, Fowell DJ, Binder S, Tsao B, Locksley RM, Moore KW, Kronenberg M 1997 Altered immune responses in interleukin 10 transgenic mice. J Exp Med 185: 2101-2110
3. Novac N, Heinzel T 2004 Nuclear receptors: overview and classification. Curr Drug Targets Inflamm Allergy 3:335-346
4. He B, Feng Q, Mukherjee A, Lonard DM, DeMayo FJ, Katzenellenbogen BS, Lydon JP, O'Malley BW 2008 A repressive role for prohibitin in estrogen signaling. Mol Endocrinol 22:344-360
5. Penning TM, Jin Y, Rizner TL, Bauman DR 2008 Pre-receptor regulation of the androgen receptor. Mol Cell Endocrinol 281:1-8
6. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, HewisonM, Stewart PM 2004 11/3-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866
7. Adams JS, Chen H, Chun RF, Nguyen L, Wu S, Ren SY, Barsony J, Gacad MA 2003 Novel regulators of vitamin Daction and metabolism: lessons learned at the Los Angeles zoo. J Cell Biochem 88:308-314
8. Picard D 2006 Chaperoning steroid hormone action. Trends Endocrinol Metab 17:229-235
9. Zhao R, Houry WA 2005 Hsp90: a chaperone for protein folding and gene regulation. Biochem Cell Biol 83:703-710
10. Nagaich AK, Rayasam GV, Martinez ED, Becker M, Qiu Y, Johnson TA, Elbi C, Fletcher TM, John S, Hager GL 2004 Subnuclear trafficking and gene targeting by steroid receptors. Ann NY Acad Sci 1024:213-220
11. Chen H, Hu B, Huang GH, Trainor AG, Abbott DH, Adams JS 2003 Purification and characterization of a novel intracellular 17/3-estradiol binding protein in estrogen-resistant New World primate cells. J Clin Endocrinol Metab 88:501-504
12. Chen H, Arbelle JE, Gacad MA, Allegretto EA, Adams JS 1997 Vitamin D and gonadal steroid-resistant New World primate cells express an intracellular protein which competes with the estrogen receptor for binding to the estrogen response element. JClin Invest 99:669-675
13. Gacad MA, Chen H, Arbelle JE, LeBon T, Adams JS 1997 Functional characterization and purification of an intracellular vitamin D-binding protein in vitamin D-resistant new world primate cells. Amino acid sequence homology with proteins in the hsp-70 family. J Biol Chem 272:8433-8440
14. Wu S, Ren S, Chen H, Chun RF, Gacad MA, Adams JS 2000 Intracellular vitamin D binding proteins: novel facilitators of vitamin D-directed transactivation. Mol Endocrinol 14:1387-1397
15. Wu S, Chun R, Gacad MA, Ren S, Chen H, Adams JS 2002 Regulation of 1,25-dihydroxyvitamin d synthesis by intracellular vitamin d binding pro- tein-1. Endocrinology 143:4135
16. Chen H, Hewison M, Hu B, Sharma M, Sun Z, Adams JS 2004 An Hsp27-related, dominant-negative-acting intracellular estradiol-binding protein. JBiol Chem 279:29944-29951
17. Arbelle JE, Chen H, Gaead MA, Allegretto EA, Pike JW, Adams JS 1996 Inhibition of vitamin D receptor-retinoid X receptor-vitamin D response element complex formation by nuclear extracts of vitamin D-resistant New World primate cells. Endocrinology 137:786-789
18. Chen H, Hu B, Gacad MA, Adams JS 1998 Cloning and expression of a novel dominant-negative-acting estrogen response element-binding protein in the heterogeneous nuclear ribonucleoprotein family. J Biol Chem 273:31352-31357
19. Chen H, Hewison M, Adams JS 2006 Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: a novel response element binding protein. JBiol Chem 281:39114-39120
20. ChenH,HewisonM,AdamsJS2008 Controlofestradiol-directedgenetrans- activation by an intracellular estrogen-binding protein and an estrogen response element-binding protein. Mol Endocrinol 22:559-569
21. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
22. Chen H, Stuart W, Hu B, Nguyen L, Huang G, Clemens TL, Adams JS 2005 Creation of estrogen resistance in vivo by transgenic overexpression of the heterogeneous nuclear ribonucleoprotein-related estrogen response element binding protein. Endocrinology 146:4266-4273
23. Hennighausen L, Ruiz L, Wall R 1990 Transgenic animals-production of foreign proteins in milk. Curr Opin Biotechnol 1:74-78
24. Oduro AK, Fritsch MK, Murdoch FE 2008 Chromatin context dominates estrogen regulation of pS2 gene expression. Exp Cell Res 314:2796 -2810
25. Chrousos GP, Loriaux DL, Tomita M, Brandon DD, Renquist D, Albertson B, Lipsett MB 1986 The new world primates as animal models of glucocorticoid resistance. Adv Exp Med Biol 196:129-144
26. Brandon DD, Markwick AJ, Chrousos GP, Loriaux DL 1989 Glucocorticoid resistance in humans and nonhuman primates. Cancer Res 49:2203s-2213s
27. Fuller PJ, Smith BJ, Rogerson FM 2004 Cortisol resistance in the New World revisited. Trends Endocrinol Metab 15:296-299
28. Adams JS, ChenH, ChunR, GacadMA, Encinas C, RenS, NguyenL, WuS, Hewison M, Barsony J 2004 Response element binding proteins and intracel- lular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism. JSteroid Biochem Mol Biol 89-90:461-465
29. Sarvilinna N, Eronen H, Miettinen S, Vienonen A, Ylikomi T 2006 Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells. Int J Cancer 118:832-840
30. Moro M, Inada Y, Kojima M, Miyata H, Komatsu H, Torii R 1999 New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline. Eur J Pharmacol 368:57-66
31. Steinetz BG, Randolph C, Mahoney CJ 1995 Patterns of relaxin and steroids in the reproductive cycle of the common marmoset (Callithrix jacchus): effects of prostaglandin F2 alpha on relaxin and progesterone secretion during pregnancy. Biol Reprod 53:834-839
32. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res 51:3867-3873
33. Borgna JL, Rochefort H 1980 High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite. Mol Cell Endocrinol 20:71-85
34. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS 1996 Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell-and promoter-specific action of these hormones.Mol Endocrinol 10:119-131
35. Smith CL, O'Malley BW 2004 Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71
36. Hovey RC, Asai-Sato M, Warri A, Terry-Koroma B, Colyn N, Ginsburg E, Vonderhaar BK 2005 Effects of neonatal exposure to diethylstilbestrol, ta- moxifen, and toremifene on the BALB/c mouse mammary gland. Biol Reprod 72:423-435